Technology
Health
Biotechnology

Calithera Biosciences

$4.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (0.49%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CALA and other stocks, options, ETFs, and crypto commission-free!

About CALA

Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. Read More The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.

Employees
79
Headquarters
South San Francisco, California
Founded
2010
Market Cap
161.02M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
369.74K
High Today
$4.19
Low Today
$4.07
Open Price
$4.14
Volume
184.75K
52 Week High
$6.90
52 Week Low
$3.43

Collections

Technology
Health
Biotechnology
Medical
2014 IPO
US
North America
Female CEOs

CALA Earnings

-$0.61
-$0.44
-$0.26
-$0.09
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.